Evolent Health (EVH) Return on Capital Employed (2015 - 2026)

Evolent Health's Return on Capital Employed history runs 12 years deep, the most recent figure standing at 27.8% for Q1 2026.

• In Q1 2026, Return on Capital Employed fell 2625.0% year-over-year to 27.8%; the TTM figure through Mar 2026 stood at 27.8% (down 2625.0% YoY), while the FY2025 annual figure was 22.33%, down 2020.0% from the prior year.
• Return on Capital Employed was 27.8% for Q1 2026 at Evolent Health, down from 22.9% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 0.27% in Q4 2022 to a low of 27.8% in Q1 2026.
• Historically, Return on Capital Employed has averaged 4.63% across 5 years, with a median of 2.2% in 2024.
• The sharpest annual moves came in 2022 and 2026: Return on Capital Employed soared 2452 bps in 2022, then slumped 2625 bps in 2026.
• A 5-year view of Return on Capital Employed shows it stood at 0.27% in 2022, then slumped by 1424 bps to 3.56% in 2023, then surged by 37 bps to 2.24% in 2024, then plunged by 922 bps to 22.9% in 2025, then declined by 21 bps to 27.8% in 2026.
• The last three Return on Capital Employed figures came in at 27.8% (Q1 2026), 22.9% (Q4 2025), and 1.01% (Q3 2025), per Business Quant data.